Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice

JAMA. 2009 Jul 22;302(4):436-7. doi: 10.1001/jama.2009.1073.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alzheimer Disease / cerebrospinal fluid*
  • Alzheimer Disease / diagnosis*
  • Amyloid beta-Peptides / cerebrospinal fluid
  • Biomarkers / cerebrospinal fluid*
  • Clinical Trials as Topic
  • Humans
  • Patient Care
  • Peptide Fragments / cerebrospinal fluid
  • Predictive Value of Tests
  • tau Proteins / cerebrospinal fluid

Substances

  • Amyloid beta-Peptides
  • Biomarkers
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • tau Proteins